NEW YORK — CVS Health has raised the midpoint of its earnings outlook for 2016 and reiterated its five-year steady state targets. The company now expects next year’s adjusted earnings per share to range from $5.73 to $5.88, reflecting solid year-over-year growth of 11.25% to 14.25%. The bottom end of the range was increased by
NEW YORK — Walgreens Boots Alliance Inc. has the size and scope to be “one of the companies that helps shape the future of health care, pharmacy and retail on a global basis,” executive vice president and acting chief executive officer Stefano Pessina said at the company’s Analyst Day event. Pessina detailed the progress
NEW YORK — CVS Health “has made the right moves,” and is “very excited about the enterprise that we have become,” president and chief executive officer Larry Merlo said at the company’s annual Analyst Day here. CVS is well positioned to meet the changing needs of consumers, payers and providers with its integrated retail pharmacy,
